Jay E. Birnbaum
Director · Sonoma Pharmaceuticals, Inc.
Individual
- 2026
- Jan 2, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Jay E. Birnbaum's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $83.13M in VOR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jay E. Birnbaum?
Jay E. Birnbaum is a corporate insider, tracked as Director of Sonoma Pharmaceuticals, Inc. (SNOA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jay E. Birnbaum last file a Form 4?
The only primary Form 4 on record is dated 2 January 2026.